News
BioSpace data show biopharma professionals faced increased competition for fewer employment opportunities during the second ...
Zacks.com on MSN22h
AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs
AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback